GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dongkoo Bio&Pharma Co Ltd (XKRX:006620) » Definitions » Cash per Share

Dongkoo Bio&Pharma Co (XKRX:006620) Cash per Share : ₩1,241.17 (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Dongkoo Bio&Pharma Co Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Dongkoo Bio&Pharma Co's Cash per Share for the quarter that ended in Sep. 2024 was ₩1,241.17.


Dongkoo Bio&Pharma Co Cash per Share Historical Data

The historical data trend for Dongkoo Bio&Pharma Co's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dongkoo Bio&Pharma Co Cash per Share Chart

Dongkoo Bio&Pharma Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash per Share
Get a 7-Day Free Trial Premium Member Only 1,183.73 1,045.72 1,144.78 1,271.95 829.39

Dongkoo Bio&Pharma Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 816.87 829.39 711.70 860.58 1,241.17

Dongkoo Bio&Pharma Co Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Dongkoo Bio&Pharma Co's Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Dongkoo Bio&Pharma Co's Cash per Share for the quarter that ended in Sep. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dongkoo Bio&Pharma Co  (XKRX:006620) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


Dongkoo Bio&Pharma Co Cash per Share Related Terms

Thank you for viewing the detailed overview of Dongkoo Bio&Pharma Co's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Dongkoo Bio&Pharma Co Business Description

Traded in Other Exchanges
N/A
Address
B-14F, M State Building, 114, Beobwonro, Songpagu, Seoul, KOR, 05836
Dongkoo Bio&Pharma Co Ltd is engaged in the research, development, manufacture, and sale of pharmaceuticals products. The company provides products for digestants, other analgesics and antipyretics, nonsteroidal anti-inflammatory drugs, oral hypoglycemic agents, antiplatelet agents, antihistamines and anti-allergic, and decongestants and nasal sprays. It offers its products in multiple forms such as capsules, tablet, powder, granule, and liquid. The company exports its products to various countries including Vietnam, New Zealand, Thailand, Hong Kong and Singapore.

Dongkoo Bio&Pharma Co Headlines

No Headlines